In agreement, the transfection of miR-145-5p inhibitor oligonucleotide in Hs578T breast cancer cells, expressing high level of miR-145-5p (Supplementary Figure 1C), led to a decrease of Ago2 protein level compared to control inhibitor (Supplementary Figure 1D–E). Here, AGO2 is linked to breast carcinoma.